{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:50:24Z","timestamp":1773924624987,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1097\/md.0000000000011298","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T22:48:35Z","timestamp":1530053315000},"page":"e11298","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease"],"prefix":"10.1097","volume":"97","author":[{"given":"Jung-Hee","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JuAh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inchul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horyong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-76-20210226","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R2-76-20210226","doi-asserted-by":"crossref","first-page":"e8824","DOI":"10.1097\/MD.0000000000008824","article-title":"Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial","volume":"96","author":"Shi","year":"2017","journal-title":"Medicine (Baltimore"},{"key":"R3-76-20210226","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-013-1105-y","article-title":"An exploratory study of the efficacy and safety of Yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease","volume":"121","author":"Hatano","year":"2014","journal-title":"J Neural Transm (Vienna"},{"key":"R4-76-20210226","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/mds.23190","article-title":"Scales to assess sleep impairment in Parkinson's disease: critique and recommendations","volume":"25","author":"Hogl","year":"2010","journal-title":"Mov Disord"},{"key":"R5-76-20210226","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.parkreldis.2013.07.026","article-title":"Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease","volume":"19","author":"Kurtis","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"R6-76-20210226","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5664\/jcsm.3150","article-title":"Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities","volume":"9","author":"Chung","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"R7-76-20210226","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol"},{"key":"R8-76-20210226","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.sleep.2013.10.016","article-title":"Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease","volume":"15","author":"Bolitho","year":"2014","journal-title":"Sleep Med"},{"key":"R9-76-20210226","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 a randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"R10-76-20210226","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.sleep.2013.12.016","article-title":"Microsubthalamotomy improves sleep in patients affected by advanced Parkinson's disease","volume":"15","author":"Merlino","year":"2014","journal-title":"Sleep Med"},{"key":"R11-76-20210226","first-page":"149","article-title":"Multiple psychopharmacological effects of the traditional Japanese kampo medicine Yokukansan, and the brain regions it affects","volume":"8","author":"Mizoguchi","year":"2017","journal-title":"Front Pharmacol"},{"key":"R12-76-20210226","first-page":"172","article-title":"An open-label trial of Yokukansan on sleep disturbance in Alzheimer's disease and other dementia","volume":"2","author":"Hayashi","year":"2015","journal-title":"J Prev Alzheimers Dis"},{"key":"R13-76-20210226","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1254\/jphs.11079SC","article-title":"Yokukansan enhances pentobarbital-induced sleep in socially isolated mice: possible involvement of GABA(A)\u2014benzodiazepine receptor complex","volume":"116","author":"Egashira","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"R14-76-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jep.2015.11.037","article-title":"The role of the seven crude drug components in the sleep-promoting effect of Yokukansan","volume":"177","author":"Ogawa","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R15-76-20210226","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pnpbp.2009.11.019","article-title":"Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia","volume":"34","author":"Kawanabe","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R16-76-20210226","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jep.2015.02.046","article-title":"Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice","volume":"166","author":"Ueki","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R17-76-20210226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jep.2013.06.005","article-title":"Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of Yokukansan in rats","volume":"149","author":"Shoji","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"R18-76-20210226","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jep.2009.09.048","article-title":"Anxiolytic effect of a herbal medicine, Yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex","volume":"127","author":"Mizoguchi","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"R19-76-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1538\/expanim.16-0028","article-title":"Influences of Yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats","volume":"65","author":"Tamano","year":"2016","journal-title":"Exp Anim"},{"key":"R20-76-20210226","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1440-1819.2002.01006.x","article-title":"Effects of Yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects","volume":"56","author":"Aizawa","year":"2002","journal-title":"Psychiatry Clin Neurosci"},{"key":"R21-76-20210226","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.22110","article-title":"SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease","volume":"23","author":"Martinez-Martin","year":"2008","journal-title":"Mov Disord"},{"key":"R22-76-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-76-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10072-015-2409-5","article-title":"Parkinson's Disease Sleep Scale 2: application in an Italian population","volume":"37","author":"Arnaldi","year":"2016","journal-title":"Neurol Sci"},{"key":"R24-76-20210226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2869.2005.00445.x","article-title":"Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly","volume":"14","author":"Tractenberg","year":"2005","journal-title":"J Sleep Res"},{"key":"R25-76-20210226","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/nur.21745","article-title":"Reliability and validity of the 4-item version of the Korean Perceived Stress Scale","volume":"39","author":"Kim","year":"2016","journal-title":"Res Nurs Health"},{"key":"R26-76-20210226","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1088\/1361-6579\/aa9047","article-title":"Estimation of sleep stages in a healthy adult population from optical plethysmography and accelerometer signals","volume":"38","author":"Beattie","year":"2017","journal-title":"Physiol Meas"},{"key":"R28-76-20210226","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","article-title":"Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems","volume":"36","author":"Brichta","year":"2013","journal-title":"Trends Neurosci"},{"key":"R29-76-20210226","first-page":"1271","article-title":"Prefrontal hypoactivation and recovery in insomnia","volume":"31","author":"Altena","year":"2008","journal-title":"Sleep"},{"key":"R30-76-20210226","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/NDT.S136774","article-title":"Reduced prefrontal activation during verbal fluency task in chronic insomnia disorder: a multichannel near-infrared spectroscopy study","volume":"13","author":"Sun","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R31-76-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fnhum.2017.00419","article-title":"Functional magnetic resonance imaging and functional near-infrared spectroscopy: insights from combined recording studies","volume":"11","author":"Scarapicchia","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"R32-76-20210226","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/1545968316650426","article-title":"The role of the frontal lobe in complex walking among patients with Parkinson's disease and healthy older adults: An fNIRS Study","volume":"30","author":"Maidan","year":"2016","journal-title":"Neurorehabil Neural Repair"},{"key":"R33-76-20210226","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40734-017-0062-2","article-title":"A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson disease (ACCORD-PD)","volume":"4","author":"Patel","year":"2017","journal-title":"J Clin Mov Disord"},{"key":"R34-76-20210226","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"R35-76-20210226","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/ane.12347","article-title":"Evaluation of cutoff scores for the Parkinson's disease sleep scale-2","volume":"131","author":"Suzuki","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"R36-76-20210226","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol"},{"key":"R37-76-20210226","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/NMD.0b013e3182848d04","article-title":"Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment","volume":"201","author":"Garcia-Alberca","year":"2013","journal-title":"J Nerv Ment Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:15:16Z","timestamp":1620962116000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201806290-00076"}},"subtitle":["A study protocol of a randomized, double blind, placebo-controlled pilot trial"],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":36,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011298","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}